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ABSTRACT
According to existing literature, there is a suggested correlation between certain
vaccinations and oral cavity symptoms. Studies have shown that the Diphtheria, Tetanus,
Acellular Pertusis, as well as Polio Vaccinations have an association with presented symptoms of
bleeding gums, sores, ulcers, white spots in the mouth or on lips, and unpleasant breath odor.
Although these symptoms may not occur simultaneously or directly after administration of the
immunization, there has been supported evidence of correlation. Given the relevance of an
association between vaccinations and orally manifested side effects, an investigation on the
presence of such association with the widely administered flu vaccine was conducted. Data for
this work was collected from a population including undergraduate students studying at the
University of Central Florida. A brief voluntary online survey requesting demographic
information regarding administration of the vaccine as well as any experienced side effects was
used. The study was cohort in nature as it tracked subjects with known exposure to the flu shot in
the past six months to understand the outcome of interest. Results from the survey were used to
determine that there is no correlation between orally manifested side effects and administration
of the flu vaccine.
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CHAPTER ONE: INTRODUCTION
As known from existing literature, there is a suggested correlation between certain
vaccinations and symptoms manifested in the oral cavity. Studies have shown that the
Diphtheria, Tetanus, Acellular Pertusis, as well as Polio Vaccinations have an association with
presented symptoms of bleeding gums, sores, ulcers, white spots in the mouth or on lips,
unpleasant breath odor, among others that are on the more serious end of the spectrum. Given
the relevance of an association between vaccinations and orally manifested side effects, an
investigation on the presence of such association with the widely administered flu vaccine should
be conducted. There is no present research proving or otherwise refuting the existence of a
correlation thus creating a gap in current knowledge.
The purpose of this research project is to provide understanding of the way in which
vaccines negatively affect the oral cavity. The following research seeks to investigate the
correlation between the flu vaccine and any side effects manifested in the oral cavity. The
research question that is to be tested is “To what extent does the flu vaccine impact the oral
cavity?” The purpose of this study is to characterize and assess the occurrence of symptoms
commonly associated with periodontal disease and dental carries. The results of this research
project will highlight additional information for future elimination of the side effects resulting
from the administration of the flu vaccine.
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CHAPTER TWO: LITERATURE REVIEW
In a world where preventive health care is favored as opposed to disease treatment,
vaccination has become a key factor in the medical society. A vaccine is a biological preparation
that provides active acquired immunity to a particular disease [2]. Vaccines typically contain an
agent resembling the disease-causing organism made from weakened or killed forms of the
microbe, its toxins, or surface proteins. The mechanism by which it works is through tricking
the body into believing that it is experiencing a full-scale invasion by an infectious agent, thus
stimulating the body’s immune system to respond and destroy the microorganism by producing
T-lymphocytes and antibodies [2]. This primary exposure leaves the body with memory immune
cells- T-lymphocytes and B-lymphocytes that are to recognize and destroy antigens associated
with the disease if ever in contact with it in the future.

History of Vaccination
The idea of acquired immunity as a result of preliminary exposure was first introduced in
the sixteenth century by the Chinese who practiced variolation or inoculation; where material
was taken from a person infected with smallpox and “given artificially” through rubbing into
superficial scratches made in the skin, which prevented people from developing scarring from
natural smallpox [1]. In the late 1700s came the “founder of vaccinology,” Edward Jenner who
created the world’s first vaccine against smallpox using the protective effect of cowpox. This is
where the term vaccine or vaccination was derived from “Variolae Vaccinae,” which is Latin for
smallpox of the cow [1]. Later in the nineteenth century was the birth of vaccines that are made
in the laboratory. French scientist Louis Pasteur “found means of attenuating” live organisms
2

including cholera and anthrax creating a breakthrough in the Germ Theory of Diseases [1].
Progress continued into the production of vaccines that are used in modern day preventive
medicine using several methods as live attenuation, killing of whole organisms, and purification
of proteins of organisms or polysaccharides.

The Age of Preventive Healthcare
There are currently 25 diseases that can be prevented to a great extent by a vaccination.
Those are: Adenovirus, Anthrax, Diphtheria, Hepatitis A, Hepatitis B, Haemophilus influenzae
type b (Hib), Human Papillomavirus (HPV), Seasonal Influenza (flu), Japanese Encephalitis,
Measles, Meningococcal, Mumps, Pertussis, Pneumococcal, Polio, Rabies, Rotavirus, Rubella,
Shingles, Smallpox, Tetanus, Tuberculosis, Typhoid Fever, Varicella, and Yellow Fever [6]. Of
these diseases, two have been completely eradicated by their preventable vaccines; polio and
smallpox [3]. Many of them are on the verge of eradication, including measles and pertussis
(whooping cough). Based on the US Centers for Disease Control and Prevention (CDC)
recommended childhood vaccine schedule, a person will have received 69 doses of 16 vaccines
by age 18.

The Influenza Vaccine
Influenza, commonly known as the flu, is a contagious respiratory illness that is caused
by the influenza virus and infects the nose, throat, and sometimes the lungs. Seasonal influenza
epidemics lasting from October to May cause serious and widespread illnesses each year.
Disease resulting from the influenza virus affects all age groups but rates of infection are highest
in high-risk groups, which are children under five and the elderly over 65 years [4]. The average
3

annual influenza-associated death rate from respiratory and circulatory causes between 1976 and
2007 ranged from 3000 to 49 000. The annual influenza vaccination has been proven to be the
most effective strategy for the prevention of the seasonal influenza and its complications [9].
New strains of the vaccine are created with each annual flu season to accommodate for immunity
developed by the virus and assure greatest protection from the disease. The most commonly
reported side effects to the influenza vaccine have been flu-like symptoms such as fever,
soreness, and runny nose [9].

Vaccines as a Double-Edged Sword
With the great benefits presented by vaccination and their ability to prevent severe
diseases, still comes incidences of minor, and in some rare instances, serious side effects as a
result of vaccine administration. That being said, many vaccine side effects can be
asymptomatic or in some cases only present as generic cold like symptoms including headaches,
fever, or an inflammation of some sort. However, many side effects are manifested in the oral
cavity, which includes components of the mouth as the lips, mucosal lining (gums), tongue, and
teeth. This is due to the fact that “immune-mediated diseases frequently affect oral mucosa,”
often making the oral cavity “the first site of clinical manifestations” [15]. Moreover, many
systemic conditions affect the mouth. The accessibility of the oral cavity for examination allows
for early and convenient detection of disorders, such as organ damage or inflammation, that are
potentially caused as a result of vaccine administration [10]. The severity of the manifestations
can be reflective of the severity of the disease and can therefore by used “as a tool for
determining disease progression” and effective treatment plans [10].
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Vaccines and the Oral Cavity
According to existing literature, there is a suggested correlation between certain
vaccinations and symptoms manifested in the oral cavity. Studies have shown that presented
symptoms of bleeding gums, sores, ulcers, white spots in the mouth or on the lips, and
unpleasant breath odor were manifested after administration of some vaccines including
diphtheria, tetanus, acellular pertussis, and polio vaccinations. Although these symptoms may
not occur simultaneously or directly after administration of the vaccination, there has been
supported evidence of a correlation [9]. There have also been reports of adverse side effects
manifested in the oral cavity associated with vaccine administration. From 1991 until 1998, it
has been known of 18 cases of Lichen Planus in France and Italy [7]. Lichen planus is an
inflammation of the skin and mucosal membranes including those inside the mouth. The
incidences of occurrence have been reported to take place 7-120 days after vaccination against
the Hepatitis B Virus (HBV) [7]. The vaccine may have simply “stimulated the immune system
nonspecifically triggering lichen planus eruption” as occurs with other immune-related disorders
[7]. Moreover, one case of a 41-year-old Hispanic male developing pemphigus vulgaris, an
autoimmune blistering disorder of the skin and mucous membranes, was reported after the
administration of the vaccination of the human papillomavirus [12]. Furthermore, a case of a 19month-old child developing pityriasus rubra pilaris, an erythemato-squamous disease of diffuse
plaques with pityriasiform scales, has been reported two weeks following intramuscular
diphtheria-tetanus-pertussis booster and oral poliovirus vaccination [13]. Another case finding is
that of a 60-year-old male who presented with cutaneous verruca vulgaris lesions (warts) on the
lips, tongues, and buccal mucosa after receiving the human papillomavirus vaccine [14]. Eight
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other cases have been reported with similar warts and squamous cell papillomas, which are
lesions caused by quadrivalent HPV vaccination [14].
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CHAPTER THREE: METHODOLOGY
Study Design and Data Collection
A cohort descriptive correlational study design will be utilized. The targeted population
from which the data for this study will be collected is undergraduate students studying at the
University of Central Florida. This will take place through sampling a randomized group of
students in the approximately 60,000 student campus. All subjects have to be 18 years of age or
older to be eligible to participate in the study.
A brief voluntary online survey will be used to collect information in order to determine
the presence of trends following the administration of the flu vaccine. An online survey will be
created via the UCF Qualtrics account. The goal of the survey is to determine the presence of a
correlation between the flu vaccine and any orally manifested side effects. The survey will
consist of 14 questions including multiple choice as well as short response questions. The survey
will begin with a preliminary question asking for the participants consent to take part in the
following survey. Lack of consent will result in the termination of the survey and ineligibility of
the study. It will then be followed by demographic questions to determine the participants age
and gender. Academic information will also be collected to determine the participants’ academic
year in college and major. The following section will address receiving the flu vaccine and any
experienced side effects, whether orally related or flu-like, as well as severity and duration of
persistence of the symptoms, and if any medical attention was seeked. The survey is divided into
different sections and shows one question at a time. An answer of “NO” on any of the questions
exits the participant out of the survey and thanks them for their participation.
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The voluntary online survey will be distributed via online collaborative websites through
posting of announcements on different UCF affiliated pages on Facebook as well as in the
classes taught by the principal investigator on the Webcourses page of the course. This will
ensure a randomized sample. The survey will be open for respondents to complete for six weeks
from when it is released. Compensation to take part in the survey will not be provided.
Participation for the duration of the survey, which is estimated to take a maximum of 15 minutes
to complete, is merely voluntary and only according to the will of those in the targeted
population. All the surveys submitted will be completed anonymously with no identifying data
collected. The online survey presents no risk to the participants involved in completing it and
subjects have the ability to withdraw at any time; however, only fully completed surveys will be
used in the analysis process.

Data Analysis
Survey completion will be open to all students, however, only students who had received
the flu shot in the past six months will be included in data analysis. The data will include
information on the frequency of side effects resulting in proximity with administration of the flu
vaccine in college students and the presence of a correlation from these findings. The principal
investigators will be responsible for the retrieval of the data from the Qualtrics system at the
conclusion of the survey period. The data retrieved will be analyzed to determine possible trends
that point at the possibility of a correlation. It is estimated date for the investigators to complete
this study and analyze the results is the end of February of 2018; however, the data will be stored
under password protection until Spring of 2021. Participants will be provided contact
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information of the principal investigators and will be free to contact them for any information
regarding the study.
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CHAPTER FOUR: RESULTS
Sample Demographics
As the survey was widely distributed through online collaborative websites as well as
flyers around campus, containing a QR code with the link to the survey that can be scanned
through the camera of any smart phone device, it was easily accessible by students of all years
and majors; thus, allowing for a simple random sample that is representative of the population to
be obtained. The online survey was active for six weeks in which 117 responses were received
from a wide range of undergraduate students studying at the University of Central Florida. The
study sample participants consisted of students ranging from 18 to 34 years of age with a high
skew of female participants at 78.6% (n=92) and only 21.4% males (n=25). A huge majority of
the participants reported to be White at 67.5% (n=79), followed by Hispanics and Latinos,
African-Americans, and Asians. Roughly half of the participants represented science majors,
which included Health Sciences Pre-Clinical, Biomedical Sciences and Biology, representing a
combined majority of 47.8% (n=56). Other majors, such as Psychology, Finance, and Forensic
Science, represented the remaining sample participants 52.2% (n=61). Additionally, a great
amount of the sample represented upperclassmen including juniors, seniors and super-seniors at
74.3% (n=87); of which juniors comprised 60% (n=52). The Freshman class was the most
underrepresented in the population with only six participants, which could likely be a result of
selection bias as discussed in the methodological limitations section.
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Sample Participants and Side Effects Resulting from the Flu Shot
Only 86 of the 117 (73.5%) reported ever receiving the flu shot in their lives, but only 37
of these participants received the flu shot in the past six months; figure 1. To understand the
efficacy of the flu vaccine for the 2017-2018 flu season, only participants who received the flu
shot in the past six months, which are 37 responses, will be used in the data analysis process as
the baseline for comparison. Of those who received the flu shot in the past six months, only 27%
(n=10) suffered from a side effect of any kind. Side effects were divided into two categories; one
being flu-like symptoms and the other being orally-related side effects which are associated with
the mouth. All 10 participants that reported suffering from side effects following receiving the
flu shot, suffered from flu-like symptoms; however, only three of them suffered orally-related
symptoms simultaneously; figure 2.
Figure 1: Percentage of Students that Received the Flu Shot within the Past Six Months

Percentage of Students that
Received the Flu Shot
68.4

80
60
40

31.6

20
0
Received the flu shot

Did not receive the flu shot
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Figure 2: Percentage of Students Experiencing Side Effects

PERCENTAGE OF AFFECTED STUDENTS
none

flu-like

flu-like and oral

flu-like and
oral
8%
flu-like
19%

none
73%

The details of the symptoms experienced by the sampled population was also reported;
however, question regarding the specific side effects suffered by the participants were limited by
the survey system to students who answered previous questions that classified them as sufferers
of the flu vaccine. A list of common flu-like and orally-related symptoms that could occur as a
result of having the influenza virus were listed for participants to choose the ones they
experienced within three weeks of receiving the vaccine. Only three oral cavity manifested side
effects were reported, which were swelling of the lips, ulcers, and the presence of white spots in
the mouth. On the other hand, seven different flu-like side effects were reported; three dealt with
pain of the upper arm, whether it being soreness, redness, or swelling, and the other four were
headache, dizziness, weakness, and fever. Table 1 and figure 3 represent the breakdown and
frequency of occurrence of each side effect as experienced by the participants in the sample
population.

12

Table 1: Symptoms Experienced by Sample

Symptom

Symptom Type

Frequency

Percentage

Swelling of the lips
Ulcers
White spots in mouth
Weakness
Dizziness
Soreness of upper arm
Headache
Fever
Swelling of upper arm
Redness of upper arm

Orally-related
Orally-related
Orally-related
Flu-like
Flu-like
Flu-like
Flu-like
Flu-like
Flu-like
Flu-like

2
2
1
3
2
5
2
2
2
1

9%
9%
4.5%
13.6%
9%
22.7%
9%
9%
9%
4.5%

Figure 3: Frequency of Symptoms Suffered by Flu Shot Receivers in 2017

Frequency of Symptoms Suffered by Flu Shot Receivers
in 2017 5

6
5

Frequency

4

3

3
2

2

2

2

2

2

1

1

2
1

0
Swelling of Ulcers
the lips

White Weakness Dizziness Soreness Headache
Spots in
of Upper
Mouth
Arm

Fever

Swelling ofRedness of
Upper ArmUpper Arm

Symptoms

Symptom Characteristics
Moreover, participants were asked to report the particular characteristics associated with
the side effects experienced. These duration that the symptoms lasted for ranged from a day to
over a week with an average of three days experienced by 50% (n=5) of those who suffered side
13

effects. The severity of the symptoms was also expressed by the participants as pain levels
ranging from mild to unbearable using a Likert scale where 1 represented mild, or light, pain and
5 represented severely unbearable pain. A pain of level 3 was average severe. According to the
reported results, 40% (n=4) of participants suffered from a level 2 pain, which was equivalent to
moderate pain. The remaining 60% was divided evenly over a level 1, 3, and 5 pain with 20%
reported for each category. Participants were also asked to identify seeking medical attention as a
result of the severity of the symptoms experienced. Medical attention was defined as visiting the
individual’s primary care physician, going into the emergency department, or a local walk-in
clinic. Only 30% (n=3) of those who suffered from side effects needed medical attention for their
symptoms and 66.6% (n=2) of them had reported a pain level of 5 showing severely unbearable
pain; table 2.
Table 2: Duration and Severity of Side Effects

Number of
Orally-related
symptoms
1
1
0
0
0
0
0
0
1
0

Number of flulike symptoms

Duration of
symptoms

Severity of
Symptoms

3
1
1
4
1
1
4
2
1
2

3 days
Over a week
3 days
5 days
1 day
3 days
3 days
1 day
Over a week
3 days

2-moderate
5-unberable
1-mild
3-severe
1-mild
2-moderate
2-moderate
3-severe
5-unberable
2-moderate

Medical
Attention
Needed
No
Yes
No
Yes
No
No
no
No
Yes
No

In addition to studying the details of the side effects reported by participants in the
sample, the relationship between demographics and symptom rate was also explored. To quantify
the symptoms, 1 point was awarded for each flu-like symptom and 2 points were awarded for
14

each orally-related side effect reported for a maximum number of 7 points in the symptom rate.
The age of the participants who received the flu shot within the past six months (n=37) was
compared to the symptom rate reported. Participants who did not suffer from any side effects
(n=27) were awarded zero points. A scatter plot was created, figure 4, to show the results and a
line of best fit was inserted to determine the r-squared value and correlational value for the
results. The R-squared value, or coefficient of determination, is a statistical measure of how
close the data are to the regression line. For the line of best fit inserted into the scatter plot of age
versus symptom rate, the R-squared value was 0.02971, which indicates that the model is a weak
indication of the variability of the response data around the mean. The correlation coefficient, Rvalue, was calculated to be -0.3116, which shows a weak negative linear relationship and thus a
week correlation between age and symptom rate, where younger participants reported more
symptoms. Gender was another factor that was also compared to the symptom rate. A twosample Z-test was used to compare the symptom rate average of male and female participants,
which was calculated to be 0.33 for males and 0.84 for females. Using a 5% significance level to
determine if the proportions are the same, a Z-Score of 2.641 and p-value of 0.0083 were
calculated. This indicates a calculate probability of 0.8% for the averages of symptom rates for
males and females to happen randomly or by chance. A p-value that is less than 5%, as in this
case, shows a statistically significant result and allows for the rejection of the null hypothesis
stating that the proportions for males and females are the same, but rather that they signify the
appearance of a correlation between gender and symptom rate, where females are significantly
more affected than males.
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Figure 4: Symptom Rate and Age in Sample
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CHAPTER FIVE: DISCUSSION
Patterns of Vaccination
So far, this appears to be the first study to examine the effects of the flu vaccine on the
oral cavity. Our research was aimed at exploring the presence of trends associated with
symptoms experienced with receiving the flu shot for the 2017-2018 flu season. The target
population of undergraduate students at a large college campus should serve as a baseline for
generalization of the results due to the huge age range included in the sample from late teens to
mid-thirties (18-34). It can be inferred from the survey responses that between July and
December of 2017, which is the peak of the influenza infection season, only 31.6% of the student
body had received an immune protection against this virus in the form of the flu shot; not taking
into account other methods of virus protection such as the nasal flu mist vaccination. Even
though the vaccine is highly recommended yearly for individuals over the age of 6 months and is
offered at discounted prices and even for free at the university, many people refuse be vaccinated
due to a fear or misunderstanding concerning the flu vaccine. They believe that the cost
outweighs the benefit in that the flu shot causes the individual to be sick with the virus. This is a
misconception, however, as the flu-like symptoms that happen following receiving the
vaccination are common side effects that take place as part of the body’s normal immune
response to the foreign inoculated influenza virus that had just entered. In most cases, the side
effects occurring after receiving the vaccine are far less severe than the symptoms caused by
actual flu illness [2].
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Factors Affecting Symptom Rate
In looking at different factors associated with reporting side effects experienced after
receiving the flu shot, it was determined that age and gender played a role in this process.
Although a week correlational coefficient of R=-0.3116 was calculated, it can still be concluded
that the younger range of the population reported suffering from far more symptoms than the
older participants in the study. This could be due to the fact that teenagers are in the developing
process of their immune system, while those who are in their twenties are at the peak of B and T
cell production from the thymus and bone marrow leading to a better immune response [16].
Stress could also be a factor that affects the levels to which the symptoms are manifested and the
significant toll they have on an individual.
Gender was also an element in the overall results of the survey. A significantly greater
number of females participated in the survey than males which is expected since the university
student body is comprised of 55.1% females and only 44.9% males. 37 participants stated that
they had received the flu shot in the past six months; only six of them were males. This shows
that females tend to be more vigilant with their health. Of the ten participants that reported
suffering side effects, only one of them was male and his symptom rate score was 2. This is
likely due to the fact that females are more likely to report symptoms than males and that they
usually have lower tolerance for pain. Due to the fact that the severity of the symptoms
experienced by the participants were asked to be self-reported according to a Likert scale, the
subjective nature to pain tolerance could have led to more females selecting a level 5, unbearable
pain, when describing the harshness of the side effects experienced. The three participants that

18

reported getting medical attention for their symptoms were also females. Females were also the
ones to report finding a manifestation related to their oral cavity.
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CHAPTER SIX: METHODOLOGICAL LIMITATIONS
The result of this study should be considered in the context of a number of limitations.
Selection bias, sample size, subjectivity, and population representation are among the
considerations that should be revised when replicating this study.
For this study, the sample size of 117 may have not been large enough to obtain useful
data as only 37 of the survey responses were considered for the data analysis while the other 80
were disregarded as they had not received the flu shot in the past six months, which is the time
period being examined by the researchers. The relatively small sample size could have been
caused by limitations of having an online survey to collect information. Even though the survey
was widely distributed through online collaborative websites as announcements on different
UCF affiliated pages on Facebook as well as in the classes taught by the principal investigator on
the Webcourses page of the course, not all students studying at the university had access to these
online links. Efforts were also made to post flyers around campus, containing a QR code with the
link to the survey that can be scanned through the camera of any smart phone device, however,
not all students are aware of the ability to scan QR codes through a cellphone camera.
Selection bias was also apparent when considering the large number of juniors that
responded to the survey, which comprised 44.4% of the total survey responses. Even though the
survey was to be easily accessible by students of all years and majors, it seems that the majority
of students that were part of the Facebook pages where the survey link was posted were juniors.
This is mainly due to the fact that many students were recruited to take the survey from the
researcher’s classes and these classes have primarily upperclassmen causing the presence of a
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selection bias in the sample and skewing the average age and grade level of students. Moreover,
the effects of the flu shot on the oral cavity in non-college students including children and the
elderly was not investigated in this study and might add significance to the results obtained.
The online survey also led to the presence of limitations in the results. Participants were
asked to self-report symptoms suffered within three weeks of receiving the flu shot which they
could have been vaccinated with up to six months earlier from when the survey was posted. This
could have led to inaccuracy in the answers given in the survey as it is purely based on the
memory of the participants. Another limitation could be the list of symptoms given in the survey
questions for participants to select from. Although more than one answer choice can be selected
for the questions asking about symptoms and the symptom list consists of most occurring side
effects caused by the flu shot, the participant might have suffered more side effects than the ones
listed. The subjectivity of the pain levels as reported by the Likert scale could have also added to
the limitations of the results.
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CHAPTER SEVEN: CONCLUSION
One of the major questions that this study hoped to answer was whether or not a
relationship existed between receiving the flu shot and suffering from orally-related side effects.
After qualitative analysis of the survey results, it appears that there are no statistically significant
relationships amongst these variables. Rather the data shows that the vaccine effectiveness for
the 2017-2018 flu season was high against influenza A and influenza B and that the benefits of
being vaccinated against the virus outweigh the cost. Unlike some vaccinations, including
diphtheria, tetanus, acellular pertussis, and polio vaccinations, the influenza vaccine proved to
have no association with periodontal disease or dental carries. Only ulcers, white spots on the
lips, and swelling of the lips were observed with correspondence to the oral cavity, which are
common side effects associated with fighting infections.
The flu vaccine is for the most part manufactured from inactivated forms of the most
prevailing strains of the virus or ones that are evolved from previous influenza seasons. The
human body naturally reacts against any foreign invaders which explains the side effects
experienced by individuals who choose to take the flu shot. The shot, however, does not protect
against virus strains not covered by the vaccine or against flu-like symptomatic conditions
caused by several other diseases including common allergies. The eradication of side effects
from occurring completely is, up till this point, beyond medical and scientific as the human
system is more intelligent. For this reason, people who have severe allergies or previously
experienced unbearable pain from the flu shot vaccine are advised not to take it and refer to other
preventive measures against the virus.
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Although no substantial relationships were observed between receiving the flu shot and
orally-related symptoms, other interesting trends were interpreted from the data. There appeared
to be a correlation between gender and reporting of symptoms as it was significantly higher for
females. The results also showed that 80% of the symptoms reported by survey participants dealt
with pain in the upper arm encompassing swelling, redness, and soreness of the upper arm. This
inflammatory response occurs at the injection site and is caused by the needle and the
administered serum which is being fought against by the body’s immune system. Future work
may be expanded beyond this to allow the study of the effects of the flu vaccine on the oral
cavity based on screening rather than an online survey. This would allow for more accurate data
collection and validation.
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